Ferritin Arraying Without Metal Ion Impurities
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing methods for two-dimensionally arraying ferritin on a substrate often result in adverse influences due to bivalent metal ions acting as impurities, leading to unexpected interface states in quantum dots, which can negatively impact their performance.
Innovation Solution
A method involving a hydrophilic substrate with a specific amino acid sequence modification on ferritin, such as DYYSSSYYEYYS, is used to prevent metal ion binding between ferritin particles, thereby eliminating the adverse effects of impurities and allowing for a stable two-dimensional array formation without the need for bivalent metal ions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If bivalent metal ions are used for crosslinkage between ferritin particles, then two-dimensional arraying of ferritin is achieved, but metal ion impurities remain on substrate and generate unexpected interface states
Solution Approach 1:
The patent removes the harmful bivalent metal ion crosslinking step from the process. Instead of using metal ions for crosslinkage, the invention employs a peptide-modified ferritin approach where the peptide sequence itself enables the two-dimensional arraying without introducing harmful metal ion impurities that would remain on the substrate after ferritin removal.
Solution Approach 2:
The patent changes the chemical parameters of the ferritin surface by introducing a specific peptide sequence (SEQ ID NO: 5) modification. This parameter change in the surface chemistry allows ferritin particles to crosslink and form two-dimensional arrays through peptide-mediated interactions rather than metal ion crosslinking, thereby eliminating the harmful impurity effect.
2Manufacturing precision
If bivalent metal ions are used for crosslinkage, then ferritin arraying is achieved, but interface states are generated affecting quantum dot performance
Solution Approach 1:
The invention extracts and eliminates the harmful element (bivalent metal ions) from the crosslinking process. By using peptide-modified ferritin instead of metal ion crosslinking, the method achieves ferritin arraying while preventing the generation of interface states that would compromise quantum dot reliability and performance.
Solution Approach 2:
The patent introduces a peptide sequence (SEQ ID NO: 5) as an intermediary that mediates the crosslinking between ferritin particles. This peptide mediator enables the formation of two-dimensional arrays without introducing harmful metal ion impurities, thereby protecting quantum dot performance from adverse interface state effects.
3Object-affected harmful factors
If peptide modification is used for two-dimensional arraying without metal ions, then impurity effects are eliminated, but specific peptide sequence is required on ferritin surface
Solution Approach 1:
The patent modifies the surface parameters of ferritin by introducing a specific peptide sequence (SEQ ID NO: 5). This parameter change in the molecular structure enables metal-ion-free crosslinking and two-dimensional arraying, eliminating impurity effects while providing a defined structural requirement for the ferritin modification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the formation of favorable two-dimensional arrays of ferritin on substrates, suppressing the formation of unexpected interface states and enhancing the quality of quantum dots produced by removing ferritin and reducing metal oxide, thus improving the reliability and performance of quantum dots.
Implementation Method 1
wherein the surface of the substrate is hydrophilic
Implementation Method 2
After ferritin is removed by heating
Implementation Method 3
reducing metal oxide if necessary
Data Source
AI summary
A novel method for two-dimensionally arraying ferritin on a substrate is provided which obviates the need for a metal ion that permits linking between adjacent two ferritin particles. In a method of two-dimensionally arraying ferritin on a substrate, the surface of the substrate is hydrophilic, and the method includes the steps of: developing a solution containing a solvent and the ferritin on the substrate; and removing the solvent from the solution developed on the substrate, while the ferritin has an amino acid sequence set out in SEQ ID NO: 1 modified at its N-terminus.